List of Excipients in API diltiazem hydrochloride extended-release tablets
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing diltiazem hydrochloride extended-release tablets
Detailed excipient profiles for diltiazem hydrochloride extended-release tablets
Excipient focus: CARNAUBA WAX
diltiazem hydrochloride extended-release tablets drug variants containing CARNAUBA WAX
diltiazem hydrochloride extended-release tablets drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
diltiazem hydrochloride extended-release tablets drug variants containing CELLULOSE, MICROCRYSTALLINE
diltiazem hydrochloride extended-release tablets drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
diltiazem hydrochloride extended-release tablets drug variants containing CROSCARMELLOSE SODIUM
diltiazem hydrochloride extended-release tablets drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
diltiazem hydrochloride extended-release tablets drug variants containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
diltiazem hydrochloride extended-release tablets drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
diltiazem hydrochloride extended-release tablets drug variants containing HYPROMELLOSE
diltiazem hydrochloride extended-release tablets drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
diltiazem hydrochloride extended-release tablets drug variants containing MAGNESIUM STEARATE
diltiazem hydrochloride extended-release tablets drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE WAX
diltiazem hydrochloride extended-release tablets drug variants containing MICROCRYSTALLINE WAX
diltiazem hydrochloride extended-release tablets drug variants not containing MICROCRYSTALLINE WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
diltiazem hydrochloride extended-release tablets drug variants containing POLYDEXTROSE
diltiazem hydrochloride extended-release tablets drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
diltiazem hydrochloride extended-release tablets drug variants containing POLYETHYLENE GLYCOL
diltiazem hydrochloride extended-release tablets drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
diltiazem hydrochloride extended-release tablets drug variants containing POLYSORBATE 80
diltiazem hydrochloride extended-release tablets drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
diltiazem hydrochloride extended-release tablets drug variants containing POVIDONE
diltiazem hydrochloride extended-release tablets drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
diltiazem hydrochloride extended-release tablets drug variants containing SILICON DIOXIDE
diltiazem hydrochloride extended-release tablets drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE STEARATE
diltiazem hydrochloride extended-release tablets drug variants containing SUCROSE STEARATE
diltiazem hydrochloride extended-release tablets drug variants not containing SUCROSE STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
diltiazem hydrochloride extended-release tablets drug variants containing TALC
diltiazem hydrochloride extended-release tablets drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
diltiazem hydrochloride extended-release tablets drug variants containing TITANIUM DIOXIDE
diltiazem hydrochloride extended-release tablets drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch